2 ASX 200 growth shares to buy with 'immense opportunity' ahead

This pair is already going gangbusters, but imagine what would happen when interest rates flatten out then come down.

| More on:
A happy boy with his dad dabs like a hero while his father checks his phone.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Last year saw many ASX growth shares turn it around after a period of malaise.

Now, in 2024, the market is looking forward to interest rates stabilising and maybe even a rate cut or two.

The team at ECP Growth Companies Fund recently named a pair of stocks it's backing for outperformance this year:

No need for a capital raise

Virtual network provider Megaport Ltd (ASX: MP1) has already kicked off 2024 in the right way.

"Megaport outperformed in January as the company released their 2Q numbers late in the month," read the ECP memo to clients.

That update was as bullish as ECP analysts predicted, but it was apparent others weren't thinking the same way.

"While the result was in line with our expectations, the positive share price reaction on the day suggested the market was positioned differently.

"Free cash flow increased over the quarter, leading to a significant increase in the cash at bank, further allaying concerns regarding the need for a capital raise."

Even after a sensational 12 months in which the Megaport share price more than doubled, the business had future potential galore for the long-term investor.

"While the opportunity to further monetise their network fabric remains immense, it will take time."

According to CMC Invest, 10 out of 15 analysts currently agree with the ECP team that Megaport is a buy.

'Considerable runway' for these growth shares

Resmed CDI (ASX: RMD) is also off to a flying start this year, rising more than 10%.

The growth stock is now trading more than 30% higher since its September trough.

The ECP team liked what it saw from a business update last month.

"The recent quarterly result was received well by the market as it signified operational leverage and margin improvement. 

"Sleep apnoea is still a major problem and an underpenetrated market both in the US and globally, leaving a considerable growth runway available for RedMed."

ResMed currently has almost the whole sleep apnoea device market to itself.

"With other competitors still well behind, we remain positively disposed to the company's future prospects."

Currently, 18 out of 26 analysts surveyed on CMC Invest believe ResMed shares are a buy.

Motley Fool contributor Tony Yoo has positions in ResMed. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Megaport and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Megaport. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Growth Shares

3 ASX 200 shares that have returned more than 17% a year over the last decade

These shares demonstrate why buy and hold investing can be a great strategy for investors.

Read more »

Two excited woman pointing out a bargain opportunity on a laptop.
Growth Shares

2 ASX growth shares with rapidly-rising dividends to buy now

Rapidly growing businesses are appealing for multiple reasons.

Read more »

a man in a green and gold Australian athletic kit roars ecstatically with a wide open mouth while his hands are clenched and raised as a shower of gold confetti falls in the sky around him.
Growth Shares

3 amazing Australian stocks to buy and hold until 2030

Analysts think these shares could be high-quality options for investors looking for long term picks.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Growth Shares

Why these ASX 200 growth shares could rise 40% in 12 months

Analysts are tipping these shares to deliver big returns over the next 12 months.

Read more »

A woman makes the task of vacuuming fun, leaping while she pretends it is an air guitar.
Opinions

Opinion: This is one of the best ASX growth shares to own for the next 5 years

This stock is rapidly growing, and I’m excited about it.

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Growth Shares

Buy Xero and this ASX 200 growth share in February

Analysts have good things to say about these growing companies.

Read more »

happy investor, share price rise, increase, up
Growth Shares

Buy these ASX growth shares with $3,000 in February

Analysts think these growth shares could be great options for investors with money to put into the share market.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Growth Shares

2 no-brainer ASX All Ords shares to buy with $2,000

Analysts have good things to say about these stocks. Let's see why they are so bullish.

Read more »